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1. Introduction
Non-invasive neurostimulation is recommended for patients with chronic neuropathic pain
lasting more than six months.
Neurostimulation methods represent a firm place in the treatment of chronic pain. In this
article, the respective mechanisms of action and efficacy of TENS(transcutaneous electrical
nerve stimulation), rTMS ( repetitive transcranial magnetic stimulation), tDCS ( transcranial
direct current stimulation) are described. In addition to the positive effects, side effects and
complications are mentioned and discussed in detail. In conclusion, neuromodulatory
(neurostimulatory) techniques are highly recommended for the treatment of different types of
pharmacoresistant pain.
2. Neurostimulation methods
Neurostimulation, as a treatment of pain method, has been shown to be beneficial for patients
suffering from pharmacoresistant chronic pain. Currently, neurostimulation methods are
indicated only after exhaustion of all other therapies; however, it is expected that, in the near
future, neurostimulation methods will become a first line treatment. Chronic pain is thought
to occur in up to 30% of the adult population, although some authors suggest that it is less than
10%; others researchers, particularly in developed countries, put the prevalence as high as 50%.
Neurostimulation methods are mainly used for chronic intractable pain, in which long-term
treatment had been ineffective. Invasive or non-invasive neurostimulation is often recom‐
mended for patients with chronic neuropathic pain lasting more than six months, which was
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
refractory to well-established first and second-line analgesic therapy or in which first and
second-line analgesic therapy produced unacceptable side effects. Most neurostimulation pain
treatments are classified based on invasivity; they are classified as either invasive or non-
invasive [29-32].
3. Invasive neurostimulation methods
• PNS - peripheral nerve stimulation SCS (spinal cord stimulation) - stimulation of the
anterolateral and dorsal spinal cord tracts
• DBS - Deep brain stimulation
• MCS -Motor cortex stimulation [29]
• Stimulation of vagus nerve [37]
• Occipital nerve stimulation [22,23]
4. Non-invasive stimulation methods
• TENS (transcutaneous electrical nerve stimulation)
• rTMS (repetitive transcranial magnetic stimulation) [10]
• tDCS (transcranial direct current stimulation)
5. Transcutaneous electrical nerve stimulation (TENS)
TENS is a simple and relatively little used method with several probable mechanisms of
pain  relief  [10].  These  techniques  are  rather  inexpensive  and non-invasive,  but  the  evi‐
dence for their effectiveness is overall of low quality [26]. The restrictive definition of TENS
is  the  administration  by  surface  electrodes  of  electric  current  produced  by  a  device  to
stimulate cutaneous sensory nerves to reduce pain,  both acute and chronic.  TENS treat‐
ment targets painful regions instead of specific nerves. Based on the stimulation frequen‐
cy,  TENS  can  be  subdivided  in  low  frequency  (frequency  <  10  Hz)  or  high  frequency
(frequency > 10 Hz). As the biological basis of analgesia by TENS remains speculative, the
‘gate control theory’ of pain was the most tenable explanation but now release of endoge‐
nous opioids is the most acceptable explanation. [11]
Transcutaneous electrical nerve stimulation is known to work via multiple pathways and to
have multiple indications and uses:
• TENS stimulates sensory nerves, activates the endogenous opioid system, stimulates the
release of enkephalins and endorphins and increases blood flow in the stimulated areas.
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• TENS produces pain relief at both low and high frequencies.
• TENS is  mediated via  release  of  μ  and δ  opioids  in  the  CNS and by a  reduction in
substance P.
• TENS affects the cardiovascular system: it increases heart rate and lowers blood pressure
[18,24].
• TENS has been successfully used for the treatment of pelvic pain when applied to the dam
and its dermatomes [37]
• TENS is used in geriatrics as valuable alternative treatment method for pharmacothera‐
py. [1].
• TENS can be used to treat muscle spasms and pains in specific areas such as surgical scars
or post-herpetic neuralgia.
• TENS is simple to cooperate with patients and they can use it at home for self-analgesia.
• TENS can be used as electroanalgesia, for the treatment of pain during labor; it is used along
the projections of Th10, Th 11, Th 12 and L1.
• TENS can be used as a complement of rehabilitation methods; threshold stimulation affects
spinal mechanisms and supra-threshold stimulation affects supraspinal modulating
mechanisms.
• TENS is also effective for neuropathic pain (including diabetic neuropathic pain [34], stump
and phantom pain, post-herpetic neuralgia, spinal cord injury [27,5] and fibromyalgia [4];
it has also started to be used for cancer pain [19].
• TENS is contraindicated for use in the patients with implanted pacemakers
A number of complementary therapies have been found to have some efficacy among the older
population, including acupuncture, TENS and massage. Such approaches can affect pain and
anxiety and are worth further investigation.
Difference scores for movement-evoked pain during the Timed “Up & Go” Test (TUG) which
is used in ipsilateral and contralateral knees during transcutaneous electrical nerve stimulation
(TENS). Significant decreases were observed ipsilaterally for all 3 groups (placebo TENS [P],
low-frequency TENS [LF], and high-frequency TENS [HF]). Data are expressed as the mean
and standard error of the mean. *=significantly different from baseline [33]
Difference scores for pain at rest in ipsilateral and contralateral knees during transcutaneous
electrical nerve stimulation (TENS). Significant decreases were observed ipsilaterally for all 3
groups (placebo TENS [P], low-frequency TENS [LF], and high-frequency TENS [HF]). Data
are expressed as the mean and standard error of the mean. *=significantly different from
baseline [33]




In this study, participants were able to correctly identify active TENS 92% of the time. We
previously reported similar responses to active TENS in healthy controls. Despite participants
knowing that they received active TENS, there was no difference between active TENS and
placebo TENS in subjective pain rating. Blinding of an electrical modality such as TENS has
always been difficult, and few studies have reported blinding of active TENS.[33]
In summary, the present randomized clinical trial examined the effects of single treatments of
HF-TENS and LF-TENS on knee OA pain and function. The use of various outcome measures,
different frequencies, and an improved placebo provided insight for the management of knee
OA pain with TENS. The pilot study tested a series of outcome measures designed to parallel
and validate animal models of TENS and to test the effects of TENS in a true double-blind
manner. Using PPT as an objective measure of pain sensitivity, showed that both HF-TENS
and LF-TENS reduced primary hyperalgesia and that only HF-TENS reduced secondary
hyperalgesia in people with OA. Quantitative sensory testing with cutaneous mechanical and
heat pain measures was not affected by HF-TENS, LF-TENS, or placebo TENS, suggesting that
TENS has no effect on cutaneous hyperalgesia. Alternatively, it is possible that the participants
with OA did not have cutaneous mechanical and heat hyperalgesia. All treatments had similar
but minimal effects on subjective pain measures, suggesting a placebo component of the effect
of TENS. [33]
Side effects of TENS therapy:
High frequency TENS delivered at low intensities is associated with paraesthesia over the area
of stimulation, and low frequency TENS delivered at high intensities is associated with a sharp
flicking sensation or even muscle contractions. These sensations hamper proper blinding in
controlled trials.[21]
TENS is completely contraindicated for use in patients with an implanted pacemaker.
6. Repetitive transcranial magnetic stimulation (rTMS)
Repetitive transcranial magnetic stimulation (rTMS) has been used for more than 20 years as
treatment for various neurological disorders, including the treatment of chronic pain condi‐
tions.
rTMS is a noninvasive method that rarely has any side effects.
In 2008, rTMS of the left dorsolateral prefrontal cortex was approved for treatment of depres‐
sion in the USA.
TMS can be used with a single pulse (single-pulse TMS), with a pair of applied pulses with a
variable interval (paired-pulse TMS) or with repeating pulses (repetitive) rTMS.
rTMS is distinguished according to the selected frequency; it can be fast, i.e. high-frequency
rTMS, which operate at frequencies of more than 1 Hz, or slow, i.e. low-frequency rTMS, which
operate at frequencies of 1 Hz or less.
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This classification is based on a variety of physiological effects and degrees of risk associated
with low and high frequency stimulation.
The effects of rTMS involved in a variety of mechanisms, including changes resembling
experimental synaptic long term depression (LTD) and long-potentiating (LTP) mechanisms,
activation of feedback loops, as well as changes in neuronal excitability. The treatment of pain
Figure 1. Guidelines of European Federation of Neurological Societes for the Neurostimulation Therapy in Neuropath‐
ic Pain [6].
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using rTMS began mainly as a test to demonstrate the efficiency of cortical stimulation. The
pioneers of this method were Lefaucheur et al. from Paris (2004, 2008) [11-13] and Leung et al.
(2009) [17], which when using rTMS on healthy volunteers observed a decrease in sensory pain
threshold.
Later it was shown that this effect was also present in patients suffering from various types of
chronic pain. Studies using imaging techniques have shown that rTMS causes not only
electrochemical changes in the brain, but also leads to a reorganization (changing the structure)
of the cerebral cortex and other areas of the brain associated with chronic pain.
The TMS principle involves a magnetic field, with an intensity of 1-2 T, which generates an
electric field that acts on the cell membrane of neurons and leads to changes in the electro‐
chemical membrane potential.
Mechanism of action of rTMS pain treatment: The exact mechanism behind rTMS pain relief
remains unknown. Stimulation of the motor cortex has been associated with pain relief in
various pharmacoresistant pain syndromes. Stimulation of the motor cortex using rTMS alters
the sensory threshold in healthy individuals and inhibits transmission of sensory information
in the spinothalamic tract; depending on stimulation duration of each treatment, rTMS has
been shown to induce a long-term increase in synaptic transmission.
Measurements of stimulation effects: In our research [10] we tested rTMS effects by making
before and after rTMS using a VAS (visual analogue scale) and QST (quantitative sensory
testing). QST consisted of thermal stimulation, which measured the thermal sensation
threshold and tactile sensation testing using von Frey hairs. Testing must be individualized
by establishing individual motor thresholds.
Contralateral motor stimulation provoked an immediate response and was associated with
stimulation levels that produced relief from pain. Immediately after stimulation there is a
temporary increase in pain, the changes in thermal threshold and tactile sensation. The benefits
of rTMS, in the form of pain relief, are usually seen 2 to 4 days after treatment. rTMS outcomes
depends on the origin and location of the treated pain and the degree of sensory deficit.
rTMS can also be used, in addition to its own analgesic effects, to determine if cortical brain
stimulation would be effective in a particular patient.
6.1. Types of pain suitable for rTMS stimulation
Intractable chronic pain: neuropathic pain (postherpetic neuralgia), pain after stroke, deaffer‐
entation pain (very often after brachial plexus avulsion), trigeminal neuralgia, and thalamic
pain. Other analgesic indications are atypical orofacial pain ) [10], spinal stenosis, low back
pain, phantom pain, stump pain, KRBS, fibromyalgia, and migraines.Best practices, for
neurostimulation have been standardized and are available in the European Federation of
Neurological Societies for neurostimulation therapy for neuropathic pain (G. Cruccu TZ Aziz,
L. Garcia-Larrea, d, P. Hansson, TS Jensen; J.-P. Lefaucheur, BA Simpson and RS Taylor,
European Journal of Neurology 2007).
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rTMS, used in accordance with the guidelines, is considered to be a safe and non-invasive
method of neuromodulation pain therapy. It offers an important next step in the treatment of
chronic intractable pain. Our research has confirmed the benefits of rTMS stimulation in
patients with trigeminal and orofacial pain. For most of patients, we observed a change in the
nature and a reduction in the frequency of painful episodes. Two patients in our research group
became pain-free and 1 patient was indicated for cortical stimulation two years after stimula‐
tion [8-10].
The use of rTMS in the treatment of chronic intractable pain is reserved for pain that does not
respond to analgesics and for pain in which the cause is difficult to remove. If it can be
demonstrated to have an analgesic effect, then rTMS could be considered for inclusion in the
current methods of pain treatment [30]. The advantage of magnetic stimulation is that it is a
non-invasive procedure that is not time-consuming. Before rTMS can be routinely used in the
treatment of chronic pain, it is necessary to accurately determine the amount and duration for
each stimulation session, thereby ensuring the optimal duration of effect. From our results it
is possible to conclude that the more effective rTMS was obtained with 20 Hz stimulation if
compared wit our results with 10 Hz stimulation [9]. These results were measured with
subjective evaluation of the pain, VAS, and with objective measurement using QTS. In objective
evaluation the tactile measurement proved to be more important, while the results from
measurement of thermal thresholds were not significant.The two treatment groups (active vs.
sham) were comparable with respect to baseline demographic and clinical characteristics.
rTMS was well tolerated, and no serious adverse effects were reported. In our study we
combined both, sham or real stimulation. Another advantage over other neuromodulatory
methods is the price of the equipment.
rTMS has also been tested on healthy subjects and was found to cause facilitation of motor
evoked potentials, leading to an alternative interpretation of the effects of rTMS, which
involves the activation of plasticity in the cerebral cortex [37]. Another possible pathophysio‐
logical explanation is that low-frequency stimulation (1 Hz) reduces the activity of excitatory
circuits in the human motor cortex. Our results did not completely confirm this hypothe‐
sis.rTMS has also been investigated in depression, Parkinson's disease, spinocerebellar
degeneration, epilepsy, urinary incontinence, movement disorders, chronic pain, migraines
and chronic tinnitus The method did very well in comparison with epidural motor cortex
stimulation and transcranial direct current electrical stimulation both in terms of effect and
having a favorable cost / effectiveness ratio rTMS has also been tested in monkeys Effectiveness
of rTMS also depends on the type of neuropathic pain [16,17].
Application of rTMS induces not only subjective pain relief [16,17] but also objective changes
in Quantitative Sensory Testing (QST), namely changes in thermal threshold [14,15]and the
threshold for tactile sensation [14,15]. Changes in the threshold of tactile sensation can be easily
and reliably accessed with techniques using von Frey monofilaments and a Peltier thermal
generator can be used to determine changes in thermal threshold [14,17].
Information regarding the prevalence of orofacial pain varies considerably from study to study
and depends on the source of pain, however, it appears to affect between 10 to 50% of the adult
population. The most common cause of facial pain is pain of dental origin, which begins after
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dental reparation or dental surgeries. Very often it is an intractable pain and pharmacological
treatment is unsuccessful. Recent studies have suggested the involvement of the peripheral
and central nervous system in the pathophysiology of atypical odontalgia.
Today rTMS is used with short-term success in the treatment of pain, mostly neuropathic pain.
Previous studies have confirmed the ability of high (> 1 Hz) rTMS to stimulate the M1 in the
treatment of facial pain. They have shown that the application of rTMS to the M1 changes the
thermal pain threshold in this and related areas. Also of interest is the DLPFC (dorsolateral
prefrontal cortex) coil position, which seems to have a substantial influence on neuronal
circuits involved in the processing of cognitive and emotional aspects of pain.
6.2. Other effects of rTMS on pain
1 Hz (low frequency) rTMS reduces acute pain induced by capsaicin temporarily improves
phantom pain and reduces pain in fibromyalgia High-frequency rTMS has been shown to
produce changes in the pain threshold in people with chronic pain. Higher frequency rTMS
(5-10 Hz) also reduces deafferentation intractable pain in spinal cord injury and in peripheral
nerves. We enlarged these indications of high frequency stimulation by using 20 Hz stimula‐
tion, which was found to be very suitable for treatment of orofacial pain.
rTMS suppresses the perception of painful CRPS (Complex Regional Pain Syndrome)and
suppresses neuropathic pain, in particular pain with a central origin rTMS is also effective in
treating migraines with or without aura Low-frequency vertex rTMS (1 Hz) has been shown
to have a prophylactic effect on migraines.
Our study confirmed that rTMS at a frequency of 20 Hz, functionally localized to the area of
the motor cortex contralateral to the position corresponding to the somatotopic location of the
pain source is effective in the treatment of chronic orofacial pain. Subjective evaluation of intra-
and inter-group VAS scores, compared with the control group, showed both immediate and
delayed treatment effects in subsequent measurements. The results of the VAS ratings are
consistent with results of previous studies.Changes in thermal sensation were not statistically
different between groups. Intragroup comparison confirmed the reduction of thermal
threshold for hot air stimulation after repeated rTMS application. Some studies have confirmed
the influence of rTMS to reduce the threshold for thermal stimulation of both cold air and hot
air [14,15] Other studies however, have shown an increased thermal threshold for hot air
stimulation after rTMS Inter-group comparisons of tactile sensations showed acute effects after
repeated stimulation (days 2, 4 and 5) but not when measured using a longer interval (day 21).
Confirmation of the influence of rTMS on QST, specifically its ability to reduce the threshold
for tactile (mechanical) sensation, supports the hypothesis that modulation of tactile and
thermal perception in the painful zone interacts with the analgesic effect of cortical stimulation
[15,16]
Our data are consistent with previous studies which reported that the use of a higher frequency
increased number of pulses during an rTMS application and an increased number of applica‐
tions [17] led to increased efficacy of the method in the treatment of pain. The best frequency
of stimulation for the most effective pain treatment has not yet been resolved. Our results
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support the effect of 20 Hz rTMS. rTMS appears to be a safe and potentially effective tool for
treatment of chronic migraine patients who showed resistance to pharmacological treatments
[20 ]. Further studies are needed to assess factors underlying therapeutic effects (change in
cortical excitability, better antinociceptive control).It’s also to seek for optimal stimulation
parameters (intensity,frequency, number and duration of stimulation sessions). Another
important point may be the best cortical areas to be modulated for pain control in migraine,
and the most efficacy side of stimulation, though the left side has been more frequently
employed in studies on pain control.
6.3. Complications of rTMS
Low frequency rTMS stimulation can cause nausea, probably via stimulation of the posterior
cranial fossa. rTMS of the premotor cortex reduces painful axial spasms in generalized
secondary dystonia. [14-17] rTMS can also have side effects and randomly caused convulsions
in control patients, one patient was reported to suffer from depression and parietal epilep‐
sy.Side effects include induction of epileptic seizures (less than 1% of patients), which is more
likely in high-frequency rTMS and rarely occurs in low-frequency rTMS. A more common
problem is the formation of transient pain, which is precisely located and depends on the site
of stimulation.
7. Transcranial direct current stimulation (tDCS)
Another non-invasive and simple neurostimulation technique is tDCS (transcranial direct
current stimulation), which uses a cathode and anode, and is applied to the head using a low
intensity direct current (0.029 to 0.08 mA/cm2) to stimulate the surface of the skull. tDCS is a
noninvasive stimulation technique that is affordable and easy to use compared to other
neuromodulation techniques [9].tDCS methods: anode stimulation increases cortical excita‐
bility, while cathodic stimulation decreases it. tDCS is a promising method for the treatment
of chronic pain, as well as for patients with neuropsychiatric diseases and other neurological
disorders.
7.1. Mechanisms of action tDCS
tDCS affects the brain’s motor cortex excitability, which in humans is in area M1 (gyrus
precentralis). Stimulation with the anode increases excitability of cortical brain cells by
affecting the GABAergic system through depolarization. Anode stimulation reduces GABA
concentrations in the cerebral cortex. Cathode stimulation reduces excitability of cortical brain
cells via hyperpolarization of the glutamate system. Cathode stimulation produces a homeo‐
static effect. Low electric current rapidly increases the electrical conductivity of biological
membranes by increasing permeability to ions and both small and large molecules. tDCS
increases intracellular calcium. Neuroplasticity modulates the motor cortex through changes
in opioid activity [7] glutamatergic, GABAergic, dopaminergic (D1 and D2 receptors),
serotonergic and cholinergic system [25].Nicotine reduces inhibitory plastic changes after
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cathode stimulation and facilitatory plasticity after anode stimulation. tDCS has also been
shown to stimulate glial cells; tDCS not only impacts neuroplasticity; tDCS is also neuropro‐
tective.
7.2. Therapeutic indication tDCS
Therapeutic indication include chronic neuropathic pain [13] including refractory orofacial
pain and pain after ERCP (endoscopic retrograde cholangiopancreatography), trigeminal pain,
fibromyalgia [35], phantom pain [3] and back pain[28].
Therapeutic indications for psychiatric disorders include: depression (including severe
depression), bipolar disorder, schizophrenia, Alzheimer's disease (here mainly it acts through
GABAergic pathways during anode stimulation) and modulation of associative learning.
Therapeutic indications in neurological diseases include: Parkinson's disease, postictal
problems after stroke and tinnitus.
7.3. tDCS perspectives
In particular it is useful for stimulation of the prefrontal dorsolateral cortex and other spread‐
ing localization of tDCS stimulation. [27]. In recent Study [12] they using a randomized, cross-
over design; each participant was exposed to 13 minutes of sham, unilateral-anodal or bilateral
Figure 2. The placement of cathode and anode transcranial direct current stimulation tCDS
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tDCS applied at 1.0 mA.In all tDCS conditions, the anode was placed over the “hot spot” of
the non-dominant extensor carpi radialis longus (ECRL) muscle as determined by TMS. The
order of these conditions were counterbalanced and randomized across participants, with a
one week rest between each condition. This was achieved as the tDCS machine used, allowed
for the use of a code to determine whether tDCS was active or inactive (sham). Within the sham
condition, 50% of the unilateral stimulation and 50% of the bilateral stimulation was random‐
ized for sham stimulation. Single and paired-pulse TMS was used to assess the after-effects of
unilateral, bilateral or sham stimulation on corticomotor excitability of the right M1 and motor
function of the non-dominant left ECRL. Ten single-pulse (130% of active motor threshold
[AMT]), 10 paired-pulse (70% of AMT) and 10 test (test-intensity set to produce MEPs of ~1
mV) TMS stimuli were applied over the cortical area for the left ECRL at baseline, immediately
following, 30 and 60 minutes post tDCS, with the order of TMS stimuli (single, paired-pulse
or test) prior to and following tDCS, randomized throughout the trials (30 trials in total for
each time point). Motor function was measured at each of these time points in all conditions
by having participants complete a Purdue pegboard test with their left hand only. Importantly,
all electrophysiological measures for each time point were measured prior to the performance
of the pegboard, as post MEP facilitation and the effectiveness of SICI has been shown to be
modulated immediately following the completion of the pegboard test. They examined the
effects of a single-session of unilateral stimulation, bilateral and sham stimulation on modu‐
lating motor function of the non-dominant limb and indices of corticomotor plasticity. In
healthy adults, the extent of motor function improvement and corticomotor plasticity were
similar between unilateral and bilateral tDCS. Therefore, the physiological mechanisms
regulating motor function were not different. Nevertheless, the present data indicate that tDCS
induces behavioral changes in the non-dominant hand as a consequence of mechanisms
associated with use-dependent cortical plasticity and is not influenced by the tDCS electrode
arrangement. [12]
At a cellular level, direct current stimulation (DCS) may enhance plasticity in a given synaptic
pathway while stimulated at a preferential frequency 0.1 Hz or consolidate a specific pattern
of activity presented during DCS. DCS may preferentially modulate the level of potentiation
in the activated pathway. DCS may facilitate long-term potentiation through membrane
polarization and removal of Mg+ block but only those pathways activated during DCS (by a
task or experimental stimulation) would benefit from this facilitation. DCS may be too weak
and/or unspecific in isolation to enhance synaptic efficacy, but may boost ongoing (e.g.,
Hebbian) plasticity activated by task performance (i.e., modulation of input specific plasticity
along an activated synaptic pathway while sparing quiescent synapses). In humans, transcra‐
nial electrical stimulation may also preferentially modulate networks with heightened
oscillatory activity or preferentially change the progression of an active network during
memory consolidation or synaptic downscaling [20]Anatomical specificity and functional
specificity, through either ongoing activity-selectivity or input-selectivity, are not exclusive
and may potentially be leveraged together in the development of rational tDCS protocols. In
general, we propose that understanding the basis for tDCS selectivity is essential. Although
we have focused our discussion to tDCS, the approaches described here would apply to other
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brain stimulation techniques including DBS, VNS, TMS, tRNS, and tACS as well as ultrasound
and light based approaches [2
Figure 3. Localisation of dorsolateral prefrontal cortex which is very perspective for tDCS treatment
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